TripSitter Clinic Ltd. (KETA.CN)
TripSitter Clinic Ltd. operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.19, up 35.71% on the session, giving a market capitalisation of $3.3M. Its beta of 0.22 implies it has historically moved less than the broad market.
TripSitter Clinic Ltd. operates a consultative virtual clinic and tele-health platform that connects patients to a licensed physician who can evaluate for a prescribed treatment program of low-dose oral ketamine medication in the United States. Its platform covers treatment for depression, anxiety, post-traumatic stress disorders, bipolar disorders, and obsessive-compulsive disorders. The company’s treatment subscription plan includes consultation with a physician, oral ketamine prescription medication, treatment sessions with a licensed medical practitioner, and messaging with a licensed medical practitioner. It serves clients in Arizona, California, Colorado, Florida, Georgia, Illinois, Iowa, Kentucky, Maine, Michigan, Minnesota, Mississippi, Montana, Nebraska, New Hampshire, North Dakota, Oklahoma, Tennessee, Vermont, Washington, West Virginia, Wisconsin, and Wyoming. TripSitter Clinic Ltd. is headquartered in Toronto, Canada.
TripSitter Clinic Ltd. is most often compared with the following Healthcare names: